http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105037398-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105037398-B |
| titleOfInvention | A kind of Bcr Abl amphiploid inhibitor and its production and use |
| abstract | A kind of Bcr Abl amphiploid inhibitor and its production and use.The invention discloses type I compound or its pharmaceutically acceptable salt, its structural formula is as follows.Type I compound or its pharmaceutically acceptable salt that the present invention is provided; it is used as Bcr Abl amphiploid inhibitor; tyrosine kinase activity can effectively be suppressed; it can be effectively used for the related disease treatment of such kinases abnormal activation; there is good therapeutic action to malignant tumour; the preparation method of such inhibitor is easy, with low cost, has a good application prospect. 。 |
| priorityDate | 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.